Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients (OPTIJIROVEC)

Assistance Publique - Hôpitaux de Paris

Status: Not yet enrolling

Conditions: Pneumocystis; Immunocompromised Patients

Treatments: Other: Biological sampling

Study type: Observational

Funder types: Other

Identifiers

NCT06890078

APHP231319

Details and patient eligibility

About

Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients

Enrollment: 240 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• adult patients with suspected pneumocystis
• with an indication for bronchial fibroscopy for BAL or induced sputum
• no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition

Exclusion criteria

• Pneumocystis treated for more than 72 hours
• pregnancy/breast-feeding
• adult patients deprived of liberty, protected

Trial design

240 participants in 1 patient group

Adults with suspicion of pneumocystis

Treatment:

Other: Biological sampling